Partnering & Outsourcing Editorial

  1. How CVS, Walgreens, And Walmart Will Improve Clinical Trial Recruitment 11/30/2022

    A new development could potentially change the patient recruitment challenge. In 2022, CVS, Walgreens, and Walmart officially entered the clinical trials space. The patient access capabilities of all three organizations may change the way drug developers access patients while also solving the patient diversity problem.

  2. Portage Biotech Creates A New Drug Development Model 11/21/2022

    While working for BMS, Ian Walters noticed a disturbing trend in the industry. Big Pharma companies would often lament that small biotech firms do not develop drugs the same way it is done at large companies. He is now working to change the biotech model.

  3. A 3-Point Strategy For Training Part-Time GCP Consultants 11/17/2022

    Global biopharma regulations and guidelines require that individuals involved in conducting clinical trials be qualified by a combination of education, training, and experience. The components are straightforward to implement regarding internal employees, but not so clear when it comes to part-time consultants contracted to intermittently execute specific good clinical practice (GCP) tasks. Discover three trips for training independent consultants.

  4. What Is A Risk-Based Approach To CRO Oversight? 10/20/2022

    Ian Wyglendowski, head of strategic clinical partnering at UCB, recommends taking a risk-based approach to CRO oversight. The first step is understanding the risk that exists. If an inspector walked in today and asked how you, the sponsor, could ensure that an activity you have outsourced complies with ICH GCP regulations, would you know how to answer that question?

  5. Market Outlook: How Should You Select A CRO Partner? 10/4/2022

    Research firm Industry Standard Research has released the latest edition of its Phase II/III Study Trends and Market Outlook (2022-2026) report. The goal of the report is to provide readers with a high-level view of the Phase II/III clinical development space to illustrate current market dynamics and inform strategic planning.

  6. Collaborating With Academia For Drug Discovery Targeting Immune-Mediated Diseases 9/16/2022

    Last year, Janssen Biotech and the University of Oxford established a collaboration to understand pathogenic pathways driving immune-mediated inflammatory diseases. They have been creating a cellular map of expressed genes and proteins. This article shares what the collaboration has accomplished so far.

  7. How To Become A Sponsor Of Choice For Your CRO Partners 7/26/2022

    Becoming a true sponsor of choice involves much more than simply saying the words. Drug discovery is a tough business and there are many parts that must seamlessly interact to get a product to regulatory approval.

  8. Novartis Lights A Beacon Of Hope For Diversity And Inclusion 7/21/2022

    In June 2022 Novartis announced the expansion of its Beacon of Hope program. The program is a 10-year, multimillion dollar program being conducted in collaboration with 26 historically Black colleges, universities, medical schools, Thurgood Marshall College Fund (TMCF) and other key partners.

  9. I Have Cancer, And I'm Thankful For The Life Science Industry 7/18/2022

    Your life can change in an instant. Mine changed in July 2021 when I was diagnosed with multiple myeloma. Here is why I am so thankful to pharma companies, patients, sites, and CROs.

  10. CVS Health Wants To Be Your New Clinical Research Site 7/6/2022

    CVS has been a well-regarded and recognized healthcare brand that started as a pharmacy but has since migrated into a recognized and trusted healthcare company. Now CVS is hoping to expand the relationship it has with patients by moving closer into primary care and clinical trials.